Pharmaceutical compositions for use in the therapy of blepharitis

US11684589B2 · kind B2 · utility

Assignee

• NOVALIQ GMBH · DE

Inventors

• Bernhard Günther · Dossenheim, DE
• Frank LÖSCHER · Schriesheim, DE
• Sonja KRÖSSER · Heidelberg, DE

Key dates

• Filing date: Sep 20, 2017
• Grant date: Jun 27, 2023
• Expiry date: Oct 23, 2037

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides a pharmaceutical composition comprising 1-perfluorohexyl-octane (F6H8) for use in the therapy, treatment, prevention or amelioration of anterior or posterior blepharitis, preferably posterior blepharitis or symptoms associated therewith. Furthermore, the present invention provides a pharmaceutical kit for the therapy of anterior or posterior blepharitis or symptoms associated therewith.